Your browser doesn't support javascript.
loading
Emerging Roles of YES1 in Cancer: The Putative Target in Drug Resistance.
Kook, Eunjin; Chun, Kyung-Soo; Kim, Do-Hee.
Afiliación
  • Kook E; Department of Chemistry, Kyonggi University, Suwon 16227, Republic of Korea.
  • Chun KS; College of Pharmacy, Keimyung University, Daegu 42691, Republic of Korea.
  • Kim DH; Department of Chemistry, Kyonggi University, Suwon 16227, Republic of Korea.
Int J Mol Sci ; 25(3)2024 Jan 25.
Article en En | MEDLINE | ID: mdl-38338729
ABSTRACT
Src family kinases (SFKs) are non-receptor tyrosine kinases that are recognized as proto-oncogenic products. Among SFKs, YES1 is frequently amplified and overexpressed in a variety of human tumors, including lung, breast, ovarian, and skin cancers. YES1 plays a pivotal role in promoting cell proliferation, survival, and invasiveness during tumor development. Recent findings indicate that YES1 expression and activation are associated with resistance to chemotherapeutic drugs and tyrosine kinase inhibitors in human malignancies. YES1 undergoes post-translational modifications, such as lipidation and nitrosylation, which can modulate its catalytic activity, subcellular localization, and binding affinity for substrate proteins. Therefore, we investigated the diverse mechanisms governing YES1 activation and its impact on critical intracellular signal transduction pathways. We emphasized the function of YES1 as a potential mechanism contributing to the anticancer drug resistance emergence.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Familia-src Quinasas / Neoplasias Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Familia-src Quinasas / Neoplasias Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2024 Tipo del documento: Article